FIELD: medicine.
SUBSTANCE: invention refers to a method of detecting candidate substances as preventive and therapeutic agents in pancreatitis involving: evaluating the 5-HT2A and 5-HT2B receptor linkage (pKis) activity of an analysed substance; and detecting the analysed substance as a candidate substance as a preventive and therapeutic agent in pancreatitis if the 5-HT2A receptor linkage activity exceeds the 5-HT2B receptor linkage activity at least by 1.0.
EFFECT: pancreatitis prevention and treatment.
8 cl, 3 ex, 3 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
| DERIVATIVES OF 4-(THIO- OR SELENOXANTHENE-9-YLIDENE)-PIPERIDINE OR ACRIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2002 |
|
RU2314305C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
| COMPOUNDS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, SELECTIVE ANTAGONISTS OF 5-HT -RECEPTOR | 2001 |
|
RU2280034C2 |
| COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DISORDERS | 2005 |
|
RU2420318C2 |
| DERIVATIVES OF 7-[3-[4-(6-FLUOROBENZO[D]ISOXAZOL-3-YL)-PIPERIDINE-1-YL]PROPOXY]- CHROMEN-4-ONE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION FOR INHIBITION OF D-, 5-HT- AND H-RECEPTORS AND METHOD OF INHIBITION OF D-, 5-HT- AND H-RECEPTORS IN TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA | 1998 |
|
RU2179556C2 |
| ARYLPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2189976C2 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
| CHROMAN DERIVATIVES AND APPLICATIONS THEREOF IN TREATING CNS DISORDERS | 2005 |
|
RU2396266C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
